So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the People's Republic of China and internationally. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment. As of December 31, 2020, it had approximately 6,900 medical aesthetic service providers and 4,200 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the People's Republic of China and internationally. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment. As of December 31, 2020, it had approximately 6,900 medical aesthetic service providers and 4,200 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.
IPO Year: 2019
Exchange: NASDAQ
Website: soyoung.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/22/2023 | $0.80 → $3.00 | Neutral → Buy | Citigroup |
11/26/2021 | $14.00 → $9.00 | Buy | Needham |
BEIJING, May 30, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that the Company plans to change the ratio of the American depositary shares ("ADSs") to its Class A ordinary shares from thirteen (13) ADSs representing ten (10) Class A ordinary shares to one (1) ADS representing fifteen (15) Class A ordinary shares. For the Company's ADS holders, the change in the ADS ratio will result in an effect equivalent to a proportional reverse ADS split. There will be no change to the Company's Class A ordinary shares. The eff
BEIJING, May 16, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Total revenues were RMB297.3 million (US$41.0 million[1]), compared with RMB318.3 million in the corresponding period of 2024, at the high-end of its previous guidance range.Net loss attributable to So-Young International Inc. was RMB33.1 million (US$4.6 million), compared with net loss attributable to So-Young International Inc. of RMB21.2
BEIJING, May 6, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it will report its financial results for the first quarter ended March 31, 2025, before U.S. markets open on May 16, 2025. So-Young's management will hold an earnings conference call on Friday, May 16, 2025, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-902-4272 China: 4001-201203 US: +1-888-346-8982 Hong Kong: +852-301-84992
BEIJING, April 18, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 18, 2024. The annual report is available on the Company's investor relations website at https://ir.soyoung.com/. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be
BEIJING, April 2, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that the Company had been informed by Mr. Xing Jin, the Company's chairman of the board of directors, chief executive officer, and controlling shareholder, that on March 31, 2025, Beauty & Health Holdings Limited, a company incorporated in the British Virgin Islands and controlled by Mr. Xing Jin, purchased a total of 4,544,820 American depositary shares ("ADSs") representing 3,496,015.38 Class A ordinary shares of the Company in the open market in accor
BEIJING, March 28, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Total revenues were RMB369.2 million (US$50.6 million[1]), compared with RMB390.6 million in the corresponding period of 2023, in line with previous guidance.Net loss attributable to So-Young International Inc. was RMB607.6 million (US$83.2 million), compared with net income attributable to So-Young International Inc
BEIJING, March 18, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has rescheduled the release of its financial results for the fourth quarter and full year ended December 31, 2024, to before U.S. markets open on March 28, 2025. So-Young's management will now hold an earnings conference call on Friday, March 28, 2025, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412
BEIJING, March 11, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2024, before U.S. markets open on March 20, 2025. So-Young's management will hold an earnings conference call on Thursday, March 20, 2025, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-902-4272 China: 4001-20120
BEIJING, Feb. 27, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that on February 25, 2025, the Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") approved the Company's request to transfer the listing of the Company's American depositary shares (ADSs), with every 13 ADSs representing 10 Class A ordinary shares, from The Nasdaq Global Market to The Nasdaq Capital Market. The transfer is expected to take effect at the opening of business on February 27, 2025. The trans
BEIJING, Nov. 20, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenues were RMB371.8 million (US$53.0 million[1]), compared with RMB385.3 million in the corresponding period of 2023, exceeding the high end of guidance.Net income attributable to So-Young International Inc. was RMB20.3 million (US$2.9 million), compared with net income attributable to So-Young Intern
BEIJING, May 16, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Total revenues were RMB297.3 million (US$41.0 million[1]), compared with RMB318.3 million in the corresponding period of 2024, at the high-end of its previous guidance range.Net loss attributable to So-Young International Inc. was RMB33.1 million (US$4.6 million), compared with net loss attributable to So-Young International Inc. of RMB21.2
BEIJING, May 6, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it will report its financial results for the first quarter ended March 31, 2025, before U.S. markets open on May 16, 2025. So-Young's management will hold an earnings conference call on Friday, May 16, 2025, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-902-4272 China: 4001-201203 US: +1-888-346-8982 Hong Kong: +852-301-84992
BEIJING, March 28, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Total revenues were RMB369.2 million (US$50.6 million[1]), compared with RMB390.6 million in the corresponding period of 2023, in line with previous guidance.Net loss attributable to So-Young International Inc. was RMB607.6 million (US$83.2 million), compared with net income attributable to So-Young International Inc
BEIJING, March 18, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has rescheduled the release of its financial results for the fourth quarter and full year ended December 31, 2024, to before U.S. markets open on March 28, 2025. So-Young's management will now hold an earnings conference call on Friday, March 28, 2025, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412
BEIJING, March 11, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2024, before U.S. markets open on March 20, 2025. So-Young's management will hold an earnings conference call on Thursday, March 20, 2025, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-902-4272 China: 4001-20120
BEIJING, Nov. 20, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenues were RMB371.8 million (US$53.0 million[1]), compared with RMB385.3 million in the corresponding period of 2023, exceeding the high end of guidance.Net income attributable to So-Young International Inc. was RMB20.3 million (US$2.9 million), compared with net income attributable to So-Young Intern
BEIJING, Nov. 6, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the third quarter ended September 30, 2024, before U.S. markets open on November 20, 2024. So-Young's management will hold an earnings conference call on Wednesday, November 20, 2024, at 7:00 AM U.S. Eastern Time (8:00 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-902-4272 China: 4001-201203 US: +1
BEIJING, Aug. 23, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Total revenues were RMB407.4 million (US$56.1 million[1]), compared with RMB412.1 million in the corresponding period of 2023, exceeding the high end of guidance.Net income attributable to So-Young International Inc. was RMB18.9 million (US$2.6 million), compared with net loss attributable to So-Young Internation
BEIJING, Aug. 5, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the second quarter ended June 30, 2024, before U.S. markets open on August 23, 2024. So-Young's management will hold an earnings conference call on Friday, August 23, 2024, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-902-4272 China: 4001-201203 US: +1-88
BEIJING, May 28, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Total revenues were RMB318.3 million (US$44.1 million[1]), compared with RMB310.1 million in the corresponding period of 2023, exceeding the high end of guidance.Net loss attributable to So-Young International Inc. was RMB21.2 million (US$2.9 million), compared with net loss attributable to So-Young International I
6-K - So-Young International Inc. (0001758530) (Filer)
6-K - So-Young International Inc. (0001758530) (Filer)
6-K - So-Young International Inc. (0001758530) (Filer)
20-F - So-Young International Inc. (0001758530) (Filer)
SCHEDULE 13G/A - So-Young International Inc. (0001758530) (Subject)
6-K - So-Young International Inc. (0001758530) (Filer)
6-K - So-Young International Inc. (0001758530) (Filer)
6-K - So-Young International Inc. (0001758530) (Filer)
6-K - So-Young International Inc. (0001758530) (Filer)
SCHEDULE 13G - So-Young International Inc. (0001758530) (Subject)
BEIJING, Oct. 12, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ:SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that Mr. Min Yu, Mr. Xuejian Li, Mr. Charles Zhaoxuan Yang and Mr. Harry Jiannan Wang have tendered their resignations as directors of the Company for personal reasons, effective as of October 12, 2023. The board of directors of the Company (the "Board") has approved the appointment of Ms. Nan Shen as an independent director of the Company where she will serve as the chair of the audit committee and as a member of the compensat
SC 13G/A - So-Young International Inc. (0001758530) (Subject)
SC 13G - So-Young International Inc. (0001758530) (Subject)
SC 13D - So-Young International Inc. (0001758530) (Subject)
SC 13G/A - So-Young International Inc. (0001758530) (Subject)
SC 13G - So-Young International Inc. (0001758530) (Subject)
SC 13G/A - So-Young International Inc. (0001758530) (Subject)
SC 13G/A - So-Young International Inc. (0001758530) (Subject)
SC 13G/A - So-Young International Inc. (0001758530) (Subject)
SC 13G - So-Young International Inc. (0001758530) (Subject)
SC 13G/A - So-Young International Inc. (0001758530) (Subject)
Citigroup upgraded So-Young International from Neutral to Buy and set a new price target of $3.00 from $0.80 previously
Needham reiterated coverage of So-Young Intl with a rating of Buy and set a new price target of $9.00 from $14.00 previously
Canaccord Genuity reiterated coverage of So-Young Intl with a rating of Buy and set a new price target of $14.00 from $16.00 previously
Needham reiterated coverage of So-Young Intl with a rating of Buy and set a new price target of $14.00 from $16.00 previously